{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:47:48Z","timestamp":1782766068354,"version":"3.54.5"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071055"],"award-info":[{"award-number":["82071055"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471178"],"award-info":[{"award-number":["82471178"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M740025"],"award-info":[{"award-number":["2023M740025"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M750022"],"award-info":[{"award-number":["2024M750022"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Ibrutinib, widely used in leukemia treatment, has been implicated in sensorineural hearing loss; however, its underlying mechanisms remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study investigated the impact of ibrutinib on hearing using HEI-OC1 cells, cochlear explants and C57BL\/6\u202fJ mice. We used RNA-sequences analysis to investigate the potential mechanisms of ibrutinib-induced ototoxicity. Mice received ibrutinib and auditory thresholds were assessed via auditory brainstem response testing; to assess the potential protective effects, we co-administered the caspase inhibitor Z-Val-Ala-Asp (OMe)-fluoromethylketone (Z-VAD-FMK) and monitored hearing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Z-VAD-FMK mitigated ibrutinib-induced hearing loss by inhibiting apoptosis in auditory cells. Ibrutinib exposure resulted in cochlear hair cell (HC) damage and subsequent hearing loss by inhibiting the protein kinase B and G protein-coupled receptor 83 (GPR83) pathways. RNA sequencing suggested that GPR83 protects HCs by modulating autophagy. Z-VAD-FMK application and GPR83 overexpression attenuated ibrutinib-induced cochlear HC apoptosis and auditory decline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings confirm ibrutinib\u2019s ototoxicity and highlight the protective role of GPR83 in ibrutinib-induced hearing loss, supporting future clinical investigations into Z-VAD-FMK and GPR83 as interventions for ibrutinib or other chemotherapeutic drug-induced ototoxicity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1579285","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T05:45:27Z","timestamp":1743659127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["GPR83 protects cochlear hair cells against ibrutinib-induced hearing loss through AKT signaling pathways"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuhua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanghua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-981-13-6123-4_2","article-title":"Protection of hair cells from ototoxic drug-induced hearing loss","volume":"1130","author":"Guo","year":"2019","journal-title":"Adv Exp Med Biol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7150\/thno.37362","article-title":"Inhibition of protein arginine methyltransferase 6 reduces reactive oxygen species production and attenuates aminoglycoside- and cisplatin-induced hair cell death","volume":"10","author":"He","year":"2020","journal-title":"Theranostics"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1038\/s41388-018-0550-3","article-title":"Dual inhibition of PI3K signaling and histone deacetylation halts proliferation and induces lethality in mantle cell lymphoma","volume":"38","author":"Guo","year":"2019","journal-title":"Oncogene"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3324\/haematol.2019.243543","article-title":"The regulation and function of CD20: an \"enigma\" of B-cell biology and targeted therapy","volume":"105","author":"Pavlasova","year":"2020","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1158\/1535-7163.MCT-17-1173","article-title":"Auranofin enhances Ibrutinib's anticancer activity in EGFR-mutant lung adenocarcinoma","volume":"17","author":"Hu","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1007\/s10637-016-0378-z","article-title":"Sunitinib-induced sudden hearing loss","volume":"34","author":"Dekeister","year":"2016","journal-title":"Investig New Drugs"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/jcpt.13009","article-title":"Bilateral sensorineural hearing loss induced by regorafenib","volume":"44","author":"Cheng","year":"2019","journal-title":"J Clin Pharm Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s43556-023-00156-w","article-title":"Structure, function and drug discovery of GPCR signaling","volume":"4","author":"Cheng","year":"2023","journal-title":"Mol Biomed"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","article-title":"G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery","volume":"9","author":"Zhang","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1038\/ncomms2968","article-title":"The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms","volume":"4","author":"Muller","year":"2013","journal-title":"Nat Commun"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s13311-022-01327-3","article-title":"Gpr83 Tunes nociceptor function, controlling pain","volume":"20","author":"Kim","year":"2023","journal-title":"Neurotherapeutics"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1242\/dev.098061","article-title":"Semicircular canal morphogenesis in the zebrafish inner ear requires the function of gpr126 (lauscher), an adhesion class G protein-coupled receptor gene","volume":"140","author":"Geng","year":"2013","journal-title":"Development"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0378-5955(03)00344-7","article-title":"Noise induces A1 adenosine receptor expression in the chinchilla cochlea","volume":"188","author":"Ramkumar","year":"2004","journal-title":"Hear Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"3962","DOI":"10.1523\/JNEUROSCI.3111-15.2016","article-title":"Adenosine A1 receptor protects against cisplatin ototoxicity by suppressing the NOX3\/STAT1 inflammatory pathway in the cochlea","volume":"36","author":"Kaur","year":"2016","journal-title":"J Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00441-006-0374-2","article-title":"Differential distribution of adenosine receptors in rat cochlea","volume":"328","author":"Vlajkovic","year":"2007","journal-title":"Cell Tissue Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22010003","article-title":"Regulator of G protein Signalling 4 (RGS4) as a novel target for the treatment of sensorineural hearing loss","volume":"22","author":"Fok","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"24541","DOI":"10.1038\/srep24541","article-title":"Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapy","volume":"6","author":"Herr","year":"2016","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.2174\/092986711797535254","article-title":"Ototoxicity: mechanisms of cochlear impairment and its prevention","volume":"18","author":"Tabuchi","year":"2011","journal-title":"Curr Med Chem"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuroscience.2009.02.085","article-title":"Generation of highly-reactive oxygen species is closely related to hair cell damage in rat organ of Corti treated with gentamicin","volume":"161","author":"Choung","year":"2009","journal-title":"Neuroscience"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1080\/15548627.2017.1359449","article-title":"Autophagy protects auditory hair cells against neomycin-induced damage","volume":"13","author":"He","year":"2017","journal-title":"Autophagy"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4909237","DOI":"10.1155\/2021\/4909237","article-title":"Hair cell protection from ototoxic drugs","volume":"2021","author":"Wu","year":"2021","journal-title":"Neural Plast"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.1523\/JNEUROSCI.23-14-06111.2003","article-title":"Caspase inhibitors promote vestibular hair cell survival and function after aminoglycoside treatment in vivo","volume":"23","author":"Matsui","year":"2003","journal-title":"J Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1007\/s12035-015-9469-7","article-title":"Decreased poly(ADP-ribose) polymerase 1 expression attenuates glucose oxidase-induced damage in rat Cochlear marginal Strial cells","volume":"53","author":"Zhang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.anl.2004.11.006","article-title":"Inhibition of caspases alleviates gentamicin-induced cochlear damage in guinea pigs","volume":"32","author":"Okuda","year":"2005","journal-title":"Auris Nasus Larynx"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.theriogenology.2017.11.031","article-title":"Inhibition of apoptosis by caspase inhibitor Z-VAD-FMK improves cryotolerance of in vitro derived bovine embryos","volume":"108","author":"Pero","year":"2018","journal-title":"Theriogenology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.onc.1201290","article-title":"Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cells","volume":"15","author":"Qi","year":"1997","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"114513","DOI":"10.1016\/j.bcp.2021.114513","article-title":"XIAP inhibits gentamicin-induced hair cell damage and ototoxicity through the caspase-3\/9 pathway","volume":"186","author":"Gao","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1158\/0008-5472.CAN-04-1581","article-title":"Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss","volume":"64","author":"Wang","year":"2004","journal-title":"Cancer Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"135089","DOI":"10.1016\/j.neulet.2020.135089","article-title":"Caspase inhibitor z-VAD-FMK increases the survival of hair cells after Actinomycin-D-induced damage in vitro","volume":"732","author":"Chang","year":"2020","journal-title":"Neurosci Lett"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.heares.2015.05.006","article-title":"Attenuation of hearing loss in DBA\/2J mice by anti-apoptotic treatment","volume":"327","author":"Yang","year":"2015","journal-title":"Hear Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00405-011-1487-0","article-title":"Intracochlear perfusion of leupeptin and z-VAD-FMK: influence of antiapoptotic agents on gunshot-induced hearing loss","volume":"268","author":"Abaamrane","year":"2011","journal-title":"Eur Arch Otorrinolaringol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/ptr.7018","article-title":"Neuroprotective effects of Ginkgolide B in focal cerebral ischemia through selective activation of prostaglandin E2 receptor EP4 and the downstream transactivation of epidermal growth factor receptor","volume":"35","author":"Yang","year":"2021","journal-title":"Phytother Res"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41401-018-0199-z","article-title":"Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling","volume":"40","author":"Wang","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"114045","DOI":"10.1016\/j.biopha.2022.114045","article-title":"Cisplatin-induced ototoxicity: from signaling network to therapeutic targets","volume":"157","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0378-5955(02)00634-2","article-title":"Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways","volume":"174","author":"Devarajan","year":"2002","journal-title":"Hear Res"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jnr.21168","article-title":"Antiapoptotic mechanism of cannabinoid receptor 2 agonist on cisplatin-induced apoptosis in the HEI-OC1 auditory cell line","volume":"85","author":"Jeong","year":"2007","journal-title":"J Neurosci Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"108996","DOI":"10.1016\/j.heares.2024.108996","article-title":"Noise-induced synaptic loss and its post-exposure recovery in CBA\/CaJ vs. C57BL\/6J mice","volume":"445","author":"Wu","year":"2024","journal-title":"Hear Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/s0378-5955(03)00142-4","article-title":"Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage","volume":"182","author":"Sergi","year":"2003","journal-title":"Hear Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s11060-021-03789-5","article-title":"US Food and Drug Administration regulatory updates in neuro-oncology","volume":"153","author":"Mehta","year":"2021","journal-title":"J Neuro-Oncol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"151000","DOI":"10.1016\/j.soncn.2020.151000","article-title":"US Food and Drug Administration clinical investigator inspections","volume":"36","author":"Buchmeier","year":"2020","journal-title":"Semin Oncol Nurs"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.apsb.2021.11.002","article-title":"Inhibiting DNA methylation alleviates cisplatin-induced hearing loss by decreasing oxidative stress-induced mitochondria-dependent apoptosis via the LRP1-PI3K\/AKT pathway","volume":"12","author":"He","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fphar.2014.00208","article-title":"Application of insulin-like growth factor-1 in the treatment of inner ear disorders","volume":"5","author":"Yamamoto","year":"2014","journal-title":"Front Pharmacol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/1535-7163.MCT-19-0135","article-title":"Ibrutinib potentiates Antihepatocarcinogenic efficacy of Sorafenib by targeting EGFR in tumor cells and BTK in immune cells in the stroma","volume":"19","author":"Lin","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"17010","DOI":"10.1038\/s41598-023-44259-4","article-title":"Novel GPR156 variants confirm its role in moderate sensorineural hearing loss","volume":"13","author":"Ramzan","year":"2023","journal-title":"Sci Rep"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"e56274","DOI":"10.1371\/journal.pone.0056274","article-title":"Headbobber: a combined morphogenetic and cochleosaccular mouse model to study 10qter deletions in human deafness","volume":"8","author":"Buniello","year":"2013","journal-title":"PLoS One"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"eadk2299","DOI":"10.1126\/sciadv.adk2299","article-title":"In silico transcriptome screens identify epidermal growth factor receptor inhibitors as therapeutics for noise-induced hearing loss","volume":"10","author":"Vijayakumar","year":"2024","journal-title":"Sci Adv"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1579285\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T05:45:30Z","timestamp":1743659130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1579285\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":48,"alternative-id":["10.3389\/fmed.2025.1579285"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1579285","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"article-number":"1579285"}}